A Drug Drug Interaction (DDI) Study of Baricitinib (LY3009104) and Digoxin in Healthy Participants
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of baricitinib on the levels of digoxin
in the blood stream and how long it takes the body to remove digoxin. This study will also
look at how safe and well-tolerated baricitinib is when given at the same time as digoxin in
healthy participants. This study will last approximately 3-4 weeks.